Spore.Bio closed a funding round (amount undisclosed) in Jan 2026. The company is based in Paris, France. Investors in the round: Google.Org Fund for AI in Science. Data as of 21 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
